Pregnancy Related Eye Symptoms

This piece is for general information and discussion only. It is not medical or legal advice.

1. Context

Eye symptoms during pregnancy are common, varied and sometimes linked with conditions that carry significant maternal risk. Most are benign hormonal effects, but some signal systemic disease such as pre‑eclampsia, gestational hypertension, migraine with aura or, rarely, serious neurological causes. National reviews consistently show that visual change can be an early warning sign of deteriorating maternal health, yet women often describe struggling to have these symptoms recognised as significant.

2. Evidence and policy

Guidance recognises that hormonal shifts in pregnancy can alter corneal thickness, tear production and refractive error. NICE and RCOG guidance on hypertensive disorders emphasise that visual disturbance can indicate severe disease, requiring clinical assessment. Ophthalmic societies describe a range of pregnancy‑related changes, from dry eye to exacerbation of pre‑existing diabetic retinopathy.

MBRRACE‑UK reports repeatedly highlight delays in recognising neurological and visual symptoms in life‑threatening conditions such as severe hypertension, intracranial haemorrhage and thromboembolic disease. Investigations by NHS England and HSSIB point to patterns of diagnostic overshadowing, particularly when symptoms are attributed to “normal pregnancy” without adequate assessment.

3. Pregnancy and the postnatal period

Changes can arise in any trimester but increase in relevance during the third trimester and the early postnatal days when hypertensive disorders often escalate. Visual symptoms may also appear after birth, particularly in postpartum pre‑eclampsia or following neuraxial anaesthesia complications. National guidance stresses that atypical presentations are well recognised and that symptoms can progress quickly.

4. What clinicians are expected to consider

Guidance highlights that clinicians typically assess:
• The nature of the symptom: blurred vision, floaters, flashing lights, temporary visual loss, double vision or changes in colour perception.
• The presence of headache, blood‑pressure elevation, neurological symptoms, or other systemic complaints.
• The potential for hypertensive disorders, migraine, retinal changes, or progression of diabetic eye disease.
• The possibility of rarer causes such as pituitary enlargement, central serous chorioretinopathy, or intracranial pathology.
• The impact of medications, dehydration, anaemia, or contact lens intolerance.
• Relevant investigations which may include blood pressure measurement, neurological examination, fundoscopy or urgent referral where indicated.

This reflects the broad differential diagnosis rather than suggesting action for any individual reader.

5. What women often describe raising

Investigations repeatedly note that women often report:
• Difficulty being believed when describing visual disturbance, especially where symptoms appear intermittent or hard to articulate.
• Being told symptoms are “normal” without clear explanation of when they might represent something more serious.
• Long waits for assessment, particularly in busy triage settings or when symptoms occur postnatally.
• Not recognising that visual symptoms can relate to blood pressure or neurological conditions.
• Fragmented pathways between maternity, ophthalmology and emergency services, resulting in delayed review.
• Feeling unsafe when they sense something is wrong but struggle to have concerns documented or escalated.

System watchpoints (for information only)

This section highlights system patterns seen in research, guidance and investigations. It is not medical or legal advice, and it is not a checklist for your own care.

Who the evidence represents

Most data derive from hospital‑based cohorts; community presentations, especially early in pregnancy or postnatally, are less documented. Neuro‑ophthalmic complications are rare and therefore sparsely represented in studies.

Intermittent symptoms

Visual changes that come and go can be hard to record. Investigations show that fluctuating symptoms are sometimes misinterpreted as low‑risk or attributed to anxiety.

Digital design

Electronic records often separate ophthalmic, neurological and maternity documentation. Important history elements can end up siloed.

Transitions of care

Postnatal women moving between maternity wards, community midwifery, general practice and emergency departments frequently encounter delays due to unclear ownership of care.

Co‑existing conditions

Women with pre‑existing diabetes, hypertension, migraines or autoimmune conditions face complex pathways. Reviews indicate that multidisciplinary communication is inconsistent.

What is improving

• National safety bundles for maternal hypertension now emphasise neurological and visual symptoms.
• MBRRACE reporting has increased awareness of postpartum risk.
• Growing use of integrated maternity–neurology and maternity–ophthalmology clinics in some NHS trusts.
• Professional bodies are updating guidance on diabetic retinopathy screening intervals during pregnancy.
• Digital systems increasingly allow maternity notes to flag high‑risk conditions to wider teams.

Where further improvement might come from

• Better cross‑specialty escalation protocols for visual and neurological symptoms in pregnancy and the postnatal period.
• Consistent inclusion of vision‑related prompts in triage documentation.
• Strengthened postnatal pathways ensuring timely review for symptoms emerging after discharge.
• Improved patient‑facing information that avoids minimising concerns.
• More research capturing women’s lived experiences of “atypical” presentations.

Reflective questions (off‑blog)

For clinicians

  1. How reliably are visual symptoms captured and escalated in our triage process?
  2. Do current digital systems link ophthalmic, neurological and maternity information effectively?
  3. Where in our local pathway do delays most often arise for women with visual disturbance?
  4. How do we communicate uncertainty when symptoms may be benign but also potentially significant?
  5. What opportunities exist for cross‑specialty training?

For patients and families

  1. Were visual or neurological symptoms clearly explained during pregnancy and after birth?
  2. Did you feel able to raise concerns when something did not feel right?
  3. Were symptoms documented and handed over between different teams?
  4. Did the system feel joined up when seeking assessment?
  5. What information or reassurance would have improved your experience?

Mandatory disclaimer

This article is for general information and discussion only. It is not medical or legal advice, nor a substitute for professional advice. To contribute evidence, ideas, or corrections, please email womenshealthproject@outlook.com. Please do not share personal data when emailing. Individual cases cannot be reviewed. This project does not offer any form of legal service and cannot assist with complaints, claims or individual advocacy.

This platform is independent and not affiliated with any law firm, regulator, inquiry or clinical body.

© 2026 Women’s Health Inquiry Project (WHIP). This article includes original analysis of material from publicly available national sources. It may not be reproduced without permission.

References

  1. NICE. Hypertension in pregnancy: diagnosis and management. Available at: https://www.nice.org.uk. Accessed: 08 Mar 2026.
  2. Royal College of Obstetricians and Gynaecologists. Guidance on antenatal and postnatal care. Available at: https://www.rcog.org.uk. Accessed: 08 Mar 2026.
  3. MBRRACE‑UK. Saving Lives, Improving Mothers’ Care. Available at: https://www.npeu.ox.ac.uk/mbrrace-uk. Accessed: 08 Mar 2026.
  4. NHS England. Maternal and neonatal safety improvement programme resources. Available at: https://www.england.nhs.uk. Accessed: 08 Mar 2026.
  5. HSSIB. National investigations relating to neurological deterioration in pregnancy. Available at: https://www.hssib.org.uk. Accessed: 08 Mar 2026.